We design, build, and operate custom pharmaceutical evidence pipelines — from two-week discovery sprints to fully managed AI systems integrated with your existing infrastructure.
Labs engagements are for teams that want AI built into their workflows — not accessed through a browser tab.
Internal data and AI teams building evidence platforms who need specialist knowledge of pharmacovigilance, HEOR methodology, and regulatory compliance — not just model infrastructure.
Medical and clinical functions that want structured evidence generation built into their existing tools — Veeva, SharePoint, Slack, or custom portals — rather than managing a new platform.
Seed-to-Series B companies building for regulatory submission or payer engagement who need production-grade AI evidence architecture without hiring a full data science team.
Three engagement models matched to where you are — scoping, building, or scaling. All built on the same 30+ agent EvidenceOS platform that powers Evidara.
We assess your evidence workflows, audit your data and governance, and deliver a strategic roadmap with a build vs. buy recommendation. Evidara Starter access included during assessment.
We design and build your internal pharmaceutical AI evidence capability — architecture, agent pipeline, compliance infrastructure, and integration with your existing systems. Evidara Enterprise access included during build.
We operate your evidence pipeline on an ongoing basis — architecture advisory, monthly optimization, agent updates, compliance monitoring, and on-call support. Evidara Professional access included.
30+ AI agents. 14 evidence chains. 16 biomedical databases. HIPAA + GDPR + EU AI Act compliance infrastructure. Built in 30 days by one person with AI. Everything we build for clients is built on the same EvidenceOS foundation. Build clients receive Evidara Enterprise access during the engagement — then can subscribe to Enterprise, run their own stack, or continue on Operate.
See the platform live →Contract research organizations building AI evidence capabilities to deliver faster, more rigorous evidence packages for pharmaceutical clients.
Health economics and outcomes research firms who want AI evidence synthesis built into their existing delivery processes — not another SaaS tab.
Enterprise pharmaceutical medical affairs teams building internal AI capabilities that integrate with Veeva, SharePoint, and existing HEOR workflows.
Most Labs engagements start with an Assess. Tell us about your evidence workflow and we'll tell you what's feasible and at what cost — fixed price, delivered in 3 weeks.